Journal of Antimicrobial Chemotherapy

Leading articles:

RG Finch, DI Pritchard, BW Bycroft, P Williams, and GS Stewart

Quorum sensing: a novel target for anti-infective therapy
J. Antimicrob. Chemother. 1998 42: 569-571; doi:10.1093/jac/42.5.569 [PDF] [Request Permissions]  

Reviews:

E Rubinstein and N Keller

Spiramycin renaissance
J. Antimicrob. Chemother. 1998 42: 572-576; doi:10.1093/jac/42.5.572 [PDF] [Request Permissions]  

Original articles:

MF Palepou, AP Johnson, BD Cookson, H Beattie, A Charlett, and N Woodford

Evaluation of disc diffusion and Etest for determining the susceptibility of Staphylococcus aureus to mupirocin
J. Antimicrob. Chemother. 1998 42: 577-583; doi:10.1093/jac/42.5.577 [Abstract] [PDF] [Request Permissions]  

EK Manavathu, JR Dimmock, SC Vashishtha, J Cutright, and PH Chandrasekar

In-vitro and in-vivo susceptibility of Aspergillus fumigatus to a novel conjugated styryl ketone
J. Antimicrob. Chemother. 1998 42: 585-590; doi:10.1093/jac/42.5.585 [Abstract] [PDF] [Request Permissions]  

KA Hammer, CF Carson, and TV Riley

In-vitro activity of essential oils, in particular Melaleuca alternifolia (tea tree) oil and tea tree oil products, against Candida spp
J. Antimicrob. Chemother. 1998 42: 591-595; doi:10.1093/jac/42.5.591 [Abstract] [PDF] [Request Permissions]  

KJ Williams and LJ Piddock

Accumulation of rifampicin by Escherichia coli and Staphylococcus aureus
J. Antimicrob. Chemother. 1998 42: 597-603; doi:10.1093/jac/42.5.597 [Abstract] [PDF] [Request Permissions]  

MF Palepou, AM Adebiyi, CH Tremlett, LB Jensen, and N Woodford

Molecular analysis of diverse elements mediating VanA glycopeptide resistance in enterococci
J. Antimicrob. Chemother. 1998 42: 605-612; doi:10.1093/jac/42.5.605 [Abstract] [PDF] [Request Permissions]  

VA Luna and MC Roberts

The presence of the tetO gene in a variety of tetracycline-resistant Streptococcus pneumoniae serotypes from Washington State
J. Antimicrob. Chemother. 1998 42: 613-619; doi:10.1093/jac/42.5.613 [Abstract] [PDF] [Request Permissions]  

B Yang, H Koga, H Ohno, K Ogawa, M Fukuda, Y Hirakata, S Maesaki, K Tomono, T Tashiro, and S Kohno

Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis
J. Antimicrob. Chemother. 1998 42: 621-628; doi:10.1093/jac/42.5.621 [Abstract] [PDF] [Request Permissions]  

H Akiyama, O Yamasaki, H Kanzaki, J Tada, and J Arata

Effects of sucrose and silver on Staphylococcus aureus biofilms
J. Antimicrob. Chemother. 1998 42: 629-634; doi:10.1093/jac/42.5.629 [Abstract] [PDF] [Request Permissions]  

S Saxena, JA Khan, and PC Ghosh

Toxicity and therapeutic efficacy of amphotericin B delivered through cholesterol hemisuccinate vesicles in the treatment of experimental murine aspergillosis
J. Antimicrob. Chemother. 1998 42: 635-642; doi:10.1093/jac/42.5.635 [Abstract] [PDF] [Request Permissions]  

AP Johnson, M Warner, and DC Speller

In-vitro activity of sanfetrinem against isolates of Streptococcus pneumoniae and Staphylococcus aureus
J. Antimicrob. Chemother. 1998 42: 643-646; doi:10.1093/jac/42.5.643 [Abstract] [PDF] [Request Permissions]  

F Soriano, R Fernandez-Roblas, R Calvo, G Garcia-Calvo, M Pardeiro, and A Bryskier

In-vitro antimicrobial activity of HMR 3004 (RU 64004) against erythromycin A-sensitive and -resistant Corynebacterium spp. isolated from clinical specimens
J. Antimicrob. Chemother. 1998 42: 647-649; doi:10.1093/jac/42.5.647 [Abstract] [PDF] [Request Permissions]  

AL Barry, PC Fuchs, and SD Brown

Susceptibility to RPR 106,972, quinupristin/dalfopristin and erythromycin among recent clinical isolates of enterococci, staphylococci and streptococci from North American medical centres
J. Antimicrob. Chemother. 1998 42: 651-655; doi:10.1093/jac/42.5.651 [Abstract] [PDF] [Request Permissions]  

PE Coudron and CW Stratton

In-vitro evaluation of nitrofurantoin as an alternative agent for metronidazole in combination antimicrobial therapy against Helicobacter pylori
J. Antimicrob. Chemother. 1998 42: 657-660; doi:10.1093/jac/42.5.657 [Abstract] [PDF] [Request Permissions]  

IJ Hassan, RM Stark, J Greenman, and MR Millar

Absence of a post-antibiotic effect (PAE) of beta-lactams against Helicobacter pylori NCTC 11637
J. Antimicrob. Chemother. 1998 42: 661-663; doi:10.1093/jac/42.5.661 [Abstract] [PDF] [Request Permissions]  

FG Araujo, AA Khan, A Bryskier, and JS Remington

Use of ketolides in combination with other drugs to treat experimental toxoplasmosis
J. Antimicrob. Chemother. 1998 42: 665-667; doi:10.1093/jac/42.5.665 [Abstract] [PDF] [Request Permissions]  

Letters:

PG Flanagan and A Paull

Carbon dioxide requirements of Streptococcus pneumoniae and Haemophilus influenzae
J. Antimicrob. Chemother. 1998 42: 669-670; doi:10.1093/jac/42.5.669 [PDF] [Request Permissions]  

M Donati, F Rumpianesi, F Marchetti, V Sambri, and R Cevenini

Comparative in-vitro activity of levofloxacin against Chlamydia spp.
J. Antimicrob. Chemother. 1998 42: 670-671; doi:10.1093/jac/42.5.670 [PDF] [Request Permissions]  

MA Croco, DJ Biedenbach, MA Pfaller, GV Doern, and RN Jones

In-vitro activities of gatifloxacin, sparfloxacin and trovafloxacin against 103 strains of Legionella spp.
J. Antimicrob. Chemother. 1998 42: 672-673; doi:10.1093/jac/42.5.672 [PDF] [Request Permissions]  

N van den Braak, A van Belkum, R te Witt, HA Verbrugh, and HP Endtz

Glycopeptide resistance amongst Staphylococcus spp.
J. Antimicrob. Chemother. 1998 42: 673-675; doi:10.1093/jac/42.5.673 [PDF] [Request Permissions]  

BU Bhuiyan, RA Miah, M Rahman, KM Rahman, and MJ Albert

High prevalence of ciprofloxacin resistance amongst strains of Neisseria gonorrhoeae isolated from commercial sex workers in Bangladesh
J. Antimicrob. Chemother. 1998 42: 675-676; doi:10.1093/jac/42.5.675 [PDF] [Request Permissions]  

DA Hill, T Herford, and D Parratt

Antibiotic usage and methicillin-resistant Staphylococcus aureus: an analysis of causality
J. Antimicrob. Chemother. 1998 42: 676-677; doi:10.1093/jac/42.5.676 [PDF] [Request Permissions]  

B O'Connell, R Marcus, V Broadbent, MV Williams, and H Ludlam

Can a single antibiotic policy for the empirical treatment of febrile neutropenic patients be used for all categories of haematology/oncology patient in the same institution?
J. Antimicrob. Chemother. 1998 42: 677-678; doi:10.1093/jac/42.5.677 [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.